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Abstract 
Advances in nanotechnology have seen the development of several microbiocidal nanoparticles 
displaying activity against biofilms. These applications benefit from one or more combinations of the 
nanoparticle properties. Nanoparticles may indeed concentrate drugs on their surface resulting in 
polyvalent effects and improved efficacy to fight against bacteria. Nanodiamonds (NDs) are among 
the most promising new materials for biomedical applications. We elucidate in this paper the effect 
of menthol modified nanodiamond (ND-menthol) particles on bacterial viability against Gram-
positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria. We show that while 
ND-menthol particles are non-toxic to both pathogens, they show significant antibiofilm activity. The 
presence of ND-menthol particles reduces biofilm formation more efficiently than free menthol, 
unmodified oxidized NDs and ampicillin, a commonly used antibiotic. Our findings might be thus a 
step forward towards the development of alternative non antibiotic based strategies targeting 
bacterial infections. 
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1. Introduction 
Bacterial infections are one of the most serious risks to public health. Extensive efforts have been 
devoted to develop rapid and sensitive methods for the detection, identification of the pathogen 
strain at hand and for destruction or inhibition of pathogens and their actions [1], [2], [3] and [4]. 
Despite considerable recent progress in the understanding of the mechanisms underlying bacterial 
infections, and in the development of nanostructured materials displaying antibacterial properties 
and activity against biofilms [1], [5], [6], [7] and [8], the quest to design and fabricate new 
antibacterial nanostructures remains a high research priority. Nanoparticles have been considered 
as affective solution to fight against bacterial infections [4], [9], [10], [11], [12], [13], [14] and [15]. 
Such nanostructures allow the concentration of antibacterial agents and functions on their surface 
to deliver polyvalent effects. Some materials such as silver are themselves antibacterial and can 
result in enhanced efficacy [16], [17] and [18]. Although recent studies using silver nanoparticles 
appear promising [19], the antimicrobial activity is highly dependent upon their size and shape, with 
smaller particles demonstrating greater activity [20] and [21]. More recently concerns about the 
cytotoxic effects of silver nanoparticles against human cells have been voiced [22]. Moreover, 
practical applications of Ag NPs are often hampered by the aggregation and loss of antibacterial 
activity [23]. 
 
Among the potential alternatives to these compounds are nanodiamond particles (NDs). One of the 
advantages of NDs over other carbon-based materials such as fullerenes and carbon nanotubes is 
that they are completely inert, optically transparent, biocompatible and can be functionalized in 
many ways depending on their intended ultimate application [24], [25], [26], [27], [28], [29], [30] and 
[31]. Although their in vivo toxicity depends on their particular surface characteristics [32], ND 
particles do not induce significant cytotoxicity in a variety of cell types [32], [33], [34] and [35] and 
have been used in a variety of biomedical applications. More recently, the antibacterial activity of 
diamond particles [36], [37] and [38] and their potential to interfere with biofilm formation [1] have 
been highlighted. The underlying anti-adhesive strategy proposed was based on the interfering with 
type 1 fimbriae-mediated mannose recognition events [39]. Such biofilm disrupting activity had not 
been observed previously for other glyco-nanoparticles (glyco-NPs) such as glycofullerenes, gold-
based glyco-NPs or for other multivalent mannose-derived molecules [2] and [40]. Wehling et al. 
have concluded that the bactericidal activity of diamond particles is directly linked to their surface 
chemistry, being thus the driving force of antibacterial effects [37]. 
 
In this paper, we investigate the antimicrobial properties of ND particles modified with menthol (Fig. 
1A) and their potential to inhibit the growth of Gram-positive (Staphylococcus aureus) and Gram-
negative (Escherichia coli) bacteria. 
 
Fig. 1.  (A) Schematic illustration of the stepwise chemical functionalization of nanodiamond particles 
(ND) to give the target ND-menthol cluster; (B) synthetic route to menthol derivative (2): (i) succinic 
anhydride, 4-DMAP, CHCl3, reflux, overnight, 84%; (ii) NHS, DCC, CH2Cl2, r.t, overnight, 95%. 
 
Menthol, also known as mint camphor, is a naturally occurring cyclic terpene alcohol of plant origin, 
which has been used since antiquity for medicinal purposes [41], [42] and [43]. It is a major 
constituent in the essential oils of Mentha canadensis L. (cornmint) and peppermint possessing well-
known cooling characteristics and a residual minty smell of the oil remnants from which it was 
obtained. Several studies have additionally demonstrated that next to the effect of sensory 
parameters, menthol has antibacterial and antifungal activities [44] and [45]. However, the 
antimicrobial activity was reported to be lower compared to antibiotics such as penicillin [46]. More 
recently, Imbert and co-workers showed the in vitro activity of terpenes, including that of menthol, 
against Candida biofilms [47]. We show here that ND-menthol particles affect moderately S. aureus 
and E. coli growth in a concentration dependent manner. In addition, the ND-menthol particles are 
found to inhibit S. aureus and E. coli-driven biofilm growth significantly. 
 
2. Experimental 
2.1. Materials 
Hydroxyl-terminated nanodiamond (ND-OH) particles were purchased from International 
Technology Center (Raleigh, NC, USA) and exhibit a primary average particle size of 4.0 nm. 
(1R,2S,5R)-(−)-menthol, 4-dimethylaminopyridine (4-DMAP), succinic anhydride, hexane (Hex), 
dichloromethane (CH2Cl2), chloroform (CHCl3), ethyl acetate (EtOAc), N,N′-dicyclohexylcarbodiimide 
(DCC) and N-hydroxysuccinimide (NHS) were purchased from Sigma-Aldrich and used as received. All 
microbiological media, equipment and the ampicillin were purchased from Fisher Scientific (UK). 
 
2.2. Synthesis of menthol derivative (2) 
2.2.1. Succinic acid mono-(2-isopropyl-4-methyl-cyclohexyl) ester (1) 
To the solution of menthol (0.8 g, 5 mmol) in chloroform, 4-DMAP (0.31 g, 2.5 mmol) and succinic 
anhydride (1.02 g, 10 mmol) were added. This mixture was stirred overnight under reflux. After 
solvent evaporation, the crude product was purified using flash column chromatography with 
Hex:EtOAc as eluent to give white crystals 1.1 g (84%). 1H NMR (300 MHz, CDCl3) δ 12.2–11.1 
(broad, 1H) 4.77–4.68 (m, 1H), 2.67–2.55 (m, 4H), 2.05–1.95 (m, 1H), 1.91–1.79 (m, 1H), 1.74–1.62 
(m, 2H), 1.55–1.33 (m, 2H), 1.1–0.8 (m, 10H), 0.78–0.7 (d, 3H). 
2.2.2. Succinic acid 2,5-dioxo-pyrrolidin-1-yl ester 2-isopropyl-4-methyl-cyclohexyl ester (2) 
To the solution of acid (1) (0.5 g, 1.9 mmol) in dichloromethane, N,N′-dicyclohexylcarbodiimide (0.4 
g, 1.9 mmol) and N-hydroxysuccinimide (0.22 g, 1.9 mmol) were added and the mixture was stirred 
overnight at room temperature. After filtration and solvent evaporation a white powder was 
obtained, yield: 95%. 1H NMR (300 MHz, CDCl3) δ 4.77–4.68 (m, 1H), 2.85–2.81 (s, 4H), 2.54–2.46 
(m, 4H), 2.01–1.94 (m, 1H), 1.88–1.76 (m, 1H), 1.73–1.62 (m, 2H), 1.55–1.33 (m, 2H), 1.22–0.82 (m, 
10H), 0.75–0.7 (d, 3H). 
2.3. Preparation of menthol-modified NDs (ND-menthol) 
Menthol derivative (2) (10 mM), was dissolved in 5 mL water and added to a suspension of ND-OH 
particles in water (10 mg in 5 mL). The solution was stirred at room temperature for 24 h under 
nitrogen. The resulting ND-menthol particles were isolated by centrifugation at 10,000 rpm, purified 
through four consecutive wash/centrifugation cycles at 10,000 rpm with ethanol, and water and 
finally oven dried at 50 °C for 24 h. 
 
2.4. Characterization 
2.4.1. FTIR spectroscopy 
Fourier transformed infrared (FTIR) spectra in transmission mode were recorded using a 
ThermoScientific FTIR instrument (Nicolet 8700) with a resolution of 4 cm− 1. Dried ND powder (1 
mg) was mixed with KBr powder (100 mg) in an agate mortar. The mixture was pressed into a pellet 
under 10 ton load for 2–4 min, and the spectrum was recorded immediately. Sixteen accumulative 
scans were collected. The signal from a pure KBr pellet was subtracted as a background. 
2.4.2. Particle size measurements 
ND suspensions (20 μg mL− 1) in water were sonicated. The particle size of the ND suspensions was 
measured at 25 °C using a Zetasizer Nano ZS (Malvern Instruments S.A., Worcestershire, U.K.) in 173° 
scattering geometry and the zeta potential was measured using the electrophoretic mode. 
2.4.3. Transmission electron microscope (TEM) 
TEM measurements were performed in a FEI Tecnai G2 20 equipped with EDS micro-analysis, Gatan 
energy filter (EELS), electron precision and tomography. 
2.4.4. Thermogravimetric analysis (TGA) 
Thermogravimetric analysis (TGA) measurements were made in Al2O3 crucibles in an atmosphere of 
nitrogen at a heating rate of 10 °C min− 1 using a TA Instruments Q50 thermogravimetric analyzer. 
 
2.5. Antimicrobial assays 
2.5.1. Bacterial biofilm formation 
Overnight cultures of E. coli (NCTC 8196) and S. aureus (NCTC 6571) were prepared by inoculating 10 
mL of nutrient broth and incubating at 37 °C for 18 h on a rotary shaker (Stuart Scientific) at 120 
rpm. After incubation, the cultures were diluted to OD600 of 0.1 in nutrient broth at a final volume 
of 100 mL, and a 96-well plate was set up as follows. Each assay sample required 6 wells, with 
another 6 wells for a negative control/blank, which consisted of 125 μL of sterile nutrient broth. 
Next, 110 μL of culture plus 15 μL of PBS was pipetted into the next 6 wells to act as the positive 
growth control. In the remaining wells, the assay was set up as follows: 110 μL of culture and 15 μL 
of the appropriate NDs and ampicillin solutions. Sterile nutrient broth and NDs and sterile nutrient 
broth and ampicillin were also set up in sets of six wells each to act as controls. The 96-well plate 
was incubated at 37 °C for 24 h with no agitation. After 24 h, the plate was removed from the 
incubator, and the supernatant of each well was removed by pipetting. The plates were 
subsequently allowed to dry for 15–20 min in a Class Two Microbiological Hood. Next, 125 μL of PBS 
was transferred into each well in order to remove any non-adhering cells. The PBS was then 
removed by pipetting, and the plates were again allowed to dry in the Class Two Microbiological 
Hood for 15 min. All wells were stained by adding 150 μL of 0.9% crystal violet in sterile reverse 
osmosis water, and the plates were incubated at room temperature for 15 min. After this time, the 
stain was removed by pipetting, and excess dye was washed off by manually adding and then 
removing 165 μL of PBS. To solubilize the crystal violet, 175 μL of 95% ethanol was added to each 
well, and the plates were incubated at room temperature for 30 min. The bacterial cell density was 
determined by the optical density of each well at 595 nm, using the negative control wells as blanks. 
2.5.2. Viability of bacterial biofilms 
The LIVE/DEAD® BacLight™ assay kit was used to determine the effect of ND-menthol (100 μg/mL) 
on bacterial cell viability. Overnight cultures of E. coli and S. aureus were prepared by inoculating 10 
mL of nutrient broth and incubating at 37 °C for 18 h on a rotary shaker (Stuart Scientific) at 120 
rpm, and subsequently diluted to OD600 of 0.01 in nutrient broth. ND-menthol (100 μg/mL) was 
suspended in sterile nutrient broth and added to respective cultures. The cultures were incubated in 
the presence of ND-methanol for 3 h (logarithmic growth phase) at 37 °C at 120 rpm. After 
incubation, the cultures were centrifuged at 10,000 rpm for 5 min, and the supernatant solution was 
discarded. The resulting cell pellets were washed with 1.5 mL sterile PBS, and centrifuged at 10,000 
rpm for 5 min, three times to remove media constituents that may interfere with the stain. After 
each wash the supernatant was discarded and the pellet collected. After the final wash in PBS, the 
cells were re-suspended in 1 mL PBS. On ice, equal volumes of component A and component B of the 
LIVE/DEAD® BacLight™ stains were added to the cell suspensions and thoroughly mixed by vortexing. 
Next, 3 μL of stain was added to 1 mL of culture suspension and the samples were incubated in the 
dark at room temperature for 20 min. Finally, 5 μL of the stained bacterial suspension was captured 
between a clean microscope slide and an 18 mm coverslip. Samples were visualized using a Leica TCS 
SP5 Confocal Laser Scanning Microscope. 
 
3. Results and discussion 
Covalent linking of antibacterial agents to surfaces has been considered as a reliable strategy to 
design antibacterial materials [48] and [49]. We opted here for the covalent linking of a carboxylic 
acid modified menthol derivative (1) to the hydroxyl groups of ND particles through an esterification 
reaction with the aim to determine the antibacterial properties of the menthol modified ND particles 
(Fig. 1). The successful integration of the menthol moiety onto ND was evidenced using Fourier 
transform infrared spectroscopy (FTIR) (Fig. 2A). ND-OH particles show a broad peak at 3400 cm− 1 
assigned to the vibration of surface hydroxyl groups or/and adsorbed water molecules, and an 
additional sharper one at 1633 cm− 1 due to the bending mode δ(OH) of surface hydroxyl groups on 
the NDs. In addition, the band at 1107 cm− 1 is indicative of the presence of C–O–C– functions of 
cyclic ethers. The FTIR spectrum of the ND-menthol particles displays in addition to bands at 3400 
cm− 1 (vibration of surface hydroxyl groups or/and adsorbed water molecules) 1633 cm− 1 (bending 
mode of surface hydroxyl groups) and 1107 cm− 1 is (C–O–C– functions of cyclic ethers), a band at 
1717 characteristic of the Cdouble bond; length as m-dashO stretching of the installed ester 
function. The C–H stretching vibration modes in menthol are seen between 2850 and 2970 cm− 1. 
 
Fig. 2. (A) FTIR spectra of ND-OH (black) and ND-menthol (red); (B) transmission electron microscopy 
(TEM) images of ND-menthol particles together with histogram of particle size distribution; (C) 
thermogravimetric analysis of menthol derivative (2) (green), ND-menthol (red) and ND-OH (black). 
TEM images of ND-menthol particles (Fig. 2B) reveal the presence of spherical particles with a size 
distribution in the range of 15 ± 5 nm in diameter. The hydrodynamic diameter of ND-menthol 
particles is 92 ± 10 nm, comparable to that of ND-OH (89 nm) with a zeta potential of 29.5 ± 0.5 mV, 
slightly lower than that of ND-OH (35.3 ± 1.6 mV) (Table 1). 
 
Table 1. Physico-chemical properties of ND-OH and ND-menthol. 
ND structure 
 
Hydrodynamic diameter 
(nm) 
PI 
Zeta potential 
(mV) 
 
ND-OH 89 ± 13 0.246 ± 0.002 35.3 ± 1.6 
 
ND-
menthol 
92 ± 10 
0.232 ± 0.015  29.5 ± 0.5 
 
To gain more insight onto the strength of the bonding between menthol derivative (2) to the surface 
of ND-OH particles, thermogravimetric analysis of ligand (2), ND-OH and ND-menthol particles was 
performed (Fig. 2C). The TGA thermogram of the as-received ND-OH particles indicates that they are 
stable up to 550 °C without any apparent mass loss [50] and [51]. TGA measurements indicate a 
weight loss of ≈ 7.45% above 95 °C mainly due to absorbed water [50]. Menthol derivative (2) 
decomposes beyond ≈ 150 °C. The removal of the covalently linked menthol derivative (2) shows its 
decomposition at temperatures above ≈ 200 °C. The weight loss between 200 and 300 °C 
corresponding to the removal of the menthol acid (1) is around 58% indicating a surface loading of 
menthol derivative (2) of 2.1 ± 0.2 mmol g− 1. 
 
To test the effect of ND-menthol particles on the growth of pathogens and bacteria induced biofilm 
formation, Gram-positive S. aureus and Gram-negative E. coli were used as model organisms. S. 
aureus are extremely versatile pathogenic bacteria that cause a wide range of syndromes, ranging 
from minor skin and soft tissue infections to life-threatening pneumonia [52] and [53]. Gram-
negative E. coli bacteria, widely used as a control organism in microbiological assays, are present 
within the gastro-intestinal (GI) tract, or as an intra- or extra-intestinal pathogen. A number of 
antibiotics in use today are delivered orally, and hence the ability of a compound to effect the 
normal GI flora is of prime importance. Disruption of the GI flora is not uncommon, but the complete 
removal of strains or a significant alteration in the relative proportions of the constituent organisms 
might lead to opportunistic infection by E. coli, or other organisms. Key virulence factors associated 
with this organism are attachment pili which facilitate adherence to the mucosal lining of the GI or 
urinary tract [54]. 
 
To determine the extent of the antimicrobial activity of ND-menthol particles, they must be assessed 
against those of known cytotoxic agents to give a positive control. An antibiotic sensitivity test was 
conducted using a range of 10 common antibiotics at a concentration of 1 μg mL− 1. The behavior of 
the different antibiotics towards E. coli growth was determined by the standard microbiological 
technique of measuring the size of the zone of inhibition around the point where the antibiotic was 
placed ( Fig. 3). Extremely weak inhibition was observed for penicillin G, while ciprofloxacin and 
ceftiofur showed relatively strong activity. From the results of the sensitivity test, ampicillin was 
chosen as a classical antibiotic with an intermediate effect and used for comparison in further 
experiments. 
 Fig. 3. Antibiotic action on E. coli growth on agar plates. 
The planktonic growths of S. aureus and E. coli were thus followed over a 6 hour period in the 
absence and presence of the ND-menthol particles at different concentrations (Fig. 4). As control the 
effect of bacterial growth in the presence of unmodified ND-OH (10 μg mL− 1) and ampicillin (10 μg 
mL− 1) was investigated. As shown in Fig. 4A, while ND-OH particles do not influence the planktonic 
growth of S. aureus, ND-menthol particles had a concentration dependent effect on the growth of S. 
aureus by moderately reducing the growth of the Gram-positive pathogen. However, even at the 
highest concentration test, the growth of S. aureus was significantly less effective than when an 
antibiotic was present. In the case of E. coli a similar behavior was observed ( Fig. 4B). While for the 
first 2 h, E. coli growth was inhibited in the presence of even low concentrations of ND-menthol, 
their efficiency started to be compromised partially thereafter allowing the planktonic growth of E. 
coli. The effect of ND-menthol on the growth of S. aureus and E. coli was evaluated using a 
LIVE/DEAD test (Invitrogen) following the manufacturer's instructions. In Fig. 5 show cell growth for 
S. aureus and E. coli in the absence (control) and presence of ND-menthol (100 μg/mL) and after 
being stained with the LIVE (green)/DEAD (red) stains. These data suggest that ND-menthol particles 
do not alter the bacterial viability of S. aureus and E. coli. and are thus non toxic. The toxic effects on 
membrane structures and function have generally been used to explain the antimicrobial activity of 
menthol, although the exact mechanism of action is not fully understood [44]. Menthol is believed 
to alter cell permeability by penetrating between the fatty acid chains making up the membrane 
lipid bilayers, disrupting lipid packaging and changing membrane fluidity. These phenomena result in 
major surface alterations and morphological modifications of Gram-positive and Gram-negative 
bacteria and in leakage of intracellular materials. Linking of menthol to ND particles seems to limit 
the bactericidal activity of menthol. It is indeed in general believed, that the antibacterial effect of 
diamond particles is related to its zeta-potential, where particles with positive potential 
demonstrated no effect, but those with negative zeta potential were shown to disrupt the cell wall 
and cytoplasmic membrane to release the cytoplasm from the cell [55]. ND-menthol as well as ND-
OH particles used as control have both positive zeta-potential (Table 1). More recently, Wehling et 
al. [37] studied the bactericidal activity of partially oxidized NDs. Their experiments suggested that 
the antibacterial activity of NDs is linked to the presence of partially oxidized and negatively charged 
surfaces, specifically those containing acid anhydride groups. From the FTIR image of ND-OH and 
ND-menthol particles (Fig. 2A), the presence of acid anhydride groups with an absorption band at 
around 1850–1750 cm− 1 is not visible explaining in addition to the presence of viable bacteria. 
 
Fig. 4. Growth curves of (A) S. aureus and (B) E. coli in the presence of ND-OH (10 μg mL− 1), 
ampicillin (1 μg mL− 1) and ND-menthol at 1, 10 and 100 μg mL− 1. 
 
Fig. 5. Viability of S. aureus and E. coli imaged by the LIVE/DEAD® BacLight™ assay (× 40 
magnification) (a) control (no NDs present); (b) ND-menthol. Green fluorescence indicates live cells 
while red or yellow fluorescence indicates dead or compromised cells. 
While ND-menthol particles were found to not interfer with the development of the planktonic 
growth of S. aureus and E. coli, we had reasons to believe that ND-menthol particles might affect the 
adhesion capacitance of the pathogens [47]. The potential of the different nanostructures to inhibit 
S. aureus and E. coli biofilm formation was furthermore investigated. In the case of S. aureus, ND-
menthol particles exhibited dose-dependent inhibition of biofilm formation as shown in Fig. 6A. In all 
cases strong biofilm inhibition is observed with ND-menthol particles. At a particle concentration of 
100 μg mL− 1 the inhibition of biofilm formation was comparable to that of the antibiotic, ampicillin, 
used. Free menthol (100 μg mL− 1), on the other hand, did not show any significant biofilm 
inhibition. ND-OH particles exhibited a moderate biofilm inhibition even at higher concentrations. 
The reason for the increased biofilm inhibition effect of ND-menthol over free menthol is most likely 
put down to their more efficient harnessing of a multivalent effect. The difference is probably also 
driven, in part, by the intrinsic physiochemical properties of the NDs. While more detailed studies 
are needed to understand fully the antibiofilm activity of menthol modified NDs, the reported 
change in bacteria membrane fluidity in the presence of menthol [44] seems to reduce the 
adherence capacity of S. aureus. This is also valid for E. coli biofilms. In the case of E. coli, the ND-
menthol particles rival with that of ampicillin even at the lowest concentration level ( Fig. 6B), with 
high ND-menthol concentrations resulted in strong biofilm inhibition.  
 
4. Conclusion 
 
In this work, we have demonstrated that menthol-conjugated nanodiamond particles have marked 
effects on S. aureus and E. coli-mediated biofilm formation. The conjugation strategy developed 
based on the formation of an ester bond between the hydroxyl groups of ND and the carboxylic acid 
group of a synthetic menthol derivative (1) proved to be highly efficient for the coupling of the 
antibacterial agent. The demonstration that ND-menthol particles are able to effectively impede 
bacterial adhesion of Gram-positive and Gram-negative bacteria is consistent with our earlier 
findings that integration of a biofilm inhibitor onto diamond particles has marked E. coli anti-
adhesive activity. In addition, neither ND-OH nor menthol controls are seen to show any anti-
adhesive activity, underlying that the observed activities are specific to ND-menthol. Moreover, ND-
menthol showed better biofilm inhibition than ampicillin even at low particle concentrations. Taken 
together, the data support that the presence of menthol moiety is the primary ingredient driving the 
biofilm-inhibitory activity observed for the ND-menthol conjugate. 
 
 Fig. 6. Biofilm formation of (A) S. aureus and (B) E. coli in the absence and presence of ND-menthol 
(1, 10, 100 μg mL− 1), ND-OH (1, 10, 100 μg mL− 1), ampicillin (1 μg mL− 1) and menthol (100 μg mL− 
1). 
 
Prime novelty statement 
1. Diamond nanoparticles modified with menthol induce reduction of biofilm formation more 
efficiently than free menthol. 
2. ND-menthol particles also compete with ampicillin, a commonly used antibiotic. 
3. Our findings might be thus a step forward towards the development of alternative non-antibiotic 
based strategies targeting bacterial infections. 
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